Healthcare Stock ,Dropped Below IPO Price, Low PE and MCAP than its PEER Group ,Now Strong on Weekly Chart, Buy, Sell or hold ?
Incorporated in 1989, GPT Healthcare Limited operates a network of mid-sized, multi-specialty hospitals in Eastern India under the ILS Hospitals brand. The company specializes in integrated healthcare services, with a strong focus on secondary and tertiary care.
Headquartered in Kolkata, West Bengal, GPT Healthcare offers a diverse range of medical services spanning over 35 specialties and super-specialties. Key areas include internal medicine, diabetology, nephrology (including kidney transplants), laparoscopic and general surgery, gynecology and obstetrics, intensive care, gastroenterology, orthopedics and joint replacement, interventional cardiology, neurology, neurosurgery, pediatrics, and neonatology. The company also provides diagnostic services and operates in-house pharmacies.
GPT Healthcare IPO Offer price was ₹ 186 ,listed on NSE ,BSE on 29Feb2024 @ ₹ 215, listing day high was @₹ 219.90 and Listing day closing was @ ₹ 200.70M @CMP is ₹181
PEER Group Business and Presance
Max healthcare
Max Healthcare Institute Limited (“Max Healthcare”) is one of India’s largest healthcare organizations, operating 22 facilities with a total capacity of over 5,000 beds. With more than 30 specialties and a team of 5,000+ clinicians, the network spans key regions, including NCR Delhi, Haryana, Punjab, Uttarakhand, Maharashtra, and Uttar Pradesh. Notably, nearly 85% of its bed capacity is located in Metro and Tier 1 cities
Apollo Hospital
Apollo Hospitals is Asia’s leading integrated healthcare services provider with a comprehensive presence across the healthcare ecosystem. Its offerings include hospitals, pharmacies, primary care and diagnostic clinics, as well as various retail health models. The group also operates telemedicine facilities across multiple countries, health insurance services, global project consultancy, medical colleges, e-learning through Medvarsity, nursing and hospital management colleges, and a dedicated research foundation.
Further enhancing its patient care continuum, Apollo Hospitals offers ASK Apollo, an online consultation portal, and Apollo Home Health, which provides healthcare services at home.
Fortis Healthcare
Fortis Healthcare Limited, a part of IHH Healthcare Berhad, is a leading integrated healthcare services provider in India. With a network of 28 healthcare facilities, over 4,500 operational beds (including O&M facilities), and 400+ diagnostic centers (including joint ventures), Fortis is one of the largest healthcare organizations in the country. The company has a presence across India, the United Arab Emirates (UAE), Nepal, and Sri Lanka. Listed on both the BSE Ltd and the National Stock Exchange (NSE) of India,
Global Health
Medanta, one of India’s largest multi-specialty tertiary care providers, was founded by Dr. Naresh Trehan, a globally acclaimed cardiovascular and cardiothoracic surgeon. Established with a mission to offer advanced yet affordable medical services, Medanta is renowned for its excellence in patient care and innovation.
Medanta Gurugram has been recognized as the best private hospital in India for four consecutive years (2020–2023). Additionally, it earned a spot on Newsweek’s list of the top 250 global hospitals in 2023, highlighting its commitment to world-class healthcare standards
PE of Peer Group
GPT Healthcare 30
Max healthcare 109
Apollo Hospital 88
Fortis Healthcare 78
Global Health 80
Out of the peer group GPT has the lowest PE
MCAP of Peer Group
GPT Healthcare ₹ 1487 Crore
Max healthcare ₹ 116,004 Crore
Apollo Hospital ₹ 104,062.71 Crore
Fortis Healthcare ₹ 51,540.99 Crore
Global Health ₹ 30,463.18 Crore
Out of the peer group GPT has the lowest lowest market Cap.
Today Closing at NSE
GPT Healthcare ₹ 181
Max healthcare ₹ 1193
Apollo Hospital ₹ 7237
Fortis Healthcare ₹ 682
Global Health ₹ 1134
GPT Healthcare
GPT HEALTHCARE Strong on Weekly Chart
GPT Healthcare is showing a strong performance on the weekly chart, with favorable indicators suggesting a promising trend. The stock has demonstrated solid volume growth over the last three weeks, reflecting growing investor interest and confidence. The price momentum has been robust, signaling a potential upward trajectory in the near term. This combination of increasing volume and positive price movement suggests the possibility of sustained gains, making it an attractive option for investors looking for growth in the healthcare sector.
Disclaimer
The information provided on this website is for educational and informational purposes only and should not be considered as financial, investment, or trading advice. All content, including stock analyses, market data, and opinions, is based on publicly available information believed to be accurate at the time of publication.
Discover more from MARKET BARRISTER
Subscribe to get the latest posts sent to your email.